Department of Congenital Heart Surgery, E. Meshalkin National Medical Research Center, Novosibirsk, Russian Federation.
Department of Anesthesiology, E. Meshalkin National Medical Research Center, Novosibirsk, Russian Federation.
World J Pediatr Congenit Heart Surg. 2021 Sep;12(5):605-613. doi: 10.1177/21501351211026594.
To assess the impact of diagnostic procedures in identifying residual lesions during extracorporeal membrane oxygenation (ECMO) on survival after pediatric cardiac surgery.
Between January 2012 and December 2017, 74 patients required postcardiotomy ECMO. Patients were retrospectively divided into 2 groups: Group I underwent only echocardiography ([echo only] 46 patients, 62.2%) and group II (echo+) underwent additional diagnostic tests (ie, computed tomography [CT] or cardiac catheterization; 28 patients, 37.8%). Propensity score matching was used to balance the 2 groups by baseline characteristics.
Two equal groups (28 patients in each group) were formed by propensity score matching. Fourteen (50%) patients in the echo-only group and 20 (71%) patients in the echo+ group were successfully weaned from ECMO ( = .17). Four (14.3%) patients survived in the echo-only group and 15 (53.5%) patients survived in the echo+ group ( = .004). Patients in the echo+ group had a lower chance of dying compared to the echo-only group (odds ratio, 0.14.6; 95% CI, 0.039-0.52; = .003). The residual lesions, which may have served as a mortality factor, were found by autopsy in 8 (40%) patients in the echo-only group, while none were found in the echo+ group ( = .014).
The autopsies of patients who died despite postcardiotomy ECMO support showed that in 40% of cases that had been investigated by echo only, residual lesions that had not been detected by echocardiography were present. The cardiac catheterization and CT during ECMO are effective and safe for identifying residual lesions. Early detection and repair of residual lesions may increase the survival rate of pediatric cardiac patients on ECMO.
评估体外膜肺氧合(ECMO)期间诊断程序识别残余病变对儿科心脏手术后生存的影响。
2012 年 1 月至 2017 年 12 月,74 例患者需要心脏手术后 ECMO。患者回顾性分为 2 组:组 I 仅行超声心动图([仅超声心动图]46 例,62.2%)和组 II(超声心动图+)行额外的诊断性检查(即计算机断层扫描[CT]或心导管检查;28 例,37.8%)。采用倾向评分匹配法使两组在基线特征上平衡。
通过倾向评分匹配,两组形成了 28 例相等的患者。在仅超声心动图组中有 14 例(50%)患者和在超声心动图+组中有 20 例(71%)患者成功脱机(=.17)。在仅超声心动图组中有 4 例(14.3%)患者存活,而在超声心动图+组中有 15 例(53.5%)患者存活(=.004)。与仅超声心动图组相比,超声心动图+组患者死亡的可能性较低(比值比,0.14.6;95%CI,0.039-0.52;=.003)。在仅超声心动图组中,有 8 例(40%)患者尽管进行了心脏手术后 ECMO 支持,但仍死于尸检中发现的残余病变,而在超声心动图+组中则未发现(=.014)。
尽管接受了心脏手术后 ECMO 支持,但仍死于 ECMO 的患者的尸检显示,在仅通过超声心动图检查的 40%的病例中,存在未通过超声心动图检测到的残余病变。ECMO 期间的心导管检查和 CT 对识别残余病变是有效且安全的。早期发现和修复残余病变可能会提高 ECMO 儿科心脏患者的存活率。